OTHER · Unmapped registry intervention
cytology specimen collection procedure
Find medicine records ·
Find other trials using this name
Clinical trial
Genetic Sequencing-Informed Targeted Therapy in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
NCT02132884
Drugs and interventions used in this trial
4 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
PROCEDURE · Unmapped registry intervention
therapeutic procedure
Find medicine records ·
Find other trials using this name
DRUG · Unmapped registry intervention
targeted therapy
Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
laboratory biomarker analysis
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedGenetic Sequencing-Informed Targeted Therapy in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
Design: INTERVENTIONAL · Status: TERMINATED · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Malignant Pericardial Effusionunresolved
Malignant Pleural Effusionunresolved
Recurrent Non-small Cell Lung Cancerunresolved
Stage IIIB Non-small Cell Lung Cancerunresolved
Stage IV Non-small Cell Lung Cancerunresolved
Interventions
Sponsors & collaborators
Fox Chase Cancer Centerlead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02132884 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.